References in periodicals archive ?
APOA5 (b) Chr11 4 1101 False LDLRAP1 Chr1 9 927 False MMP9 Chr20 13 2124 False PDGFRB Chr5 23 3321 False VEGFA Chr6 7 1239 False ACTA2 Chr10 9 1134 True APOC3 Chr11 4 300 False CAV1 Chr7 3 537 False CD40 Chr20 9 834 False CETP Chr16 16 1482 False CIITA Chr16 20 3396 False FGG Chr4 10 1362 True GPX1 Chr3 1 612 True LPL Chr8 10 1428 False MBL2 Chr10 4 747 True MVK Chr12 11 1191 False PITX2 Chr4 6 954 False TNFRSF1A Chr12 10 1368 False UCP2 Chr11 8 930 False Gene name GC content APOA5 (b) 0.
Initial cytogenetic analysis revealed a t(5;12)(q31~33;p13) in 17 of 20 cells (Figure 1(c)) and a presumptive diagnosis of myeloid neoplasm with eosinophilia and translocation t(5;12) suggestive of PDGFRB rearrangement was made.
Variante Examenes de rutina SHE-M * HLG con ESP * Triptasa y vitamina B12 * RT-PCR y/o FISH para deteccion de mutacion F/P (sangre y AMO) * Cariotipo * AMO biopsia: celularidad, |CD34, cambios displasicos, fReticulocitos, mastocitos atipicos * Evaluacion para organomegalias SHE-L * Fenotipificacion LT (minimo CD3, CD4 y CD8) * IgE, IgG, IgA, IgM * Cariotipo * Analisis del rearreglo del TCR por PCR (sangre y AMO) * FDG-PET/TC (sospecha de linforma) Variante Otros SHE-M * Busqueda de otros genes de fusion que involucren el PDGFRA y PDGFRB (RQ-PCR).
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, orFGFR1.
14) The major disease entities within this category are myeloproliferative neoplasm (MPN) with PDGFRA rearrangement, MPN with PDGFRB rearrangement, and the so-called 8p11 myeloproliferative syndrome.
Se incluyeron los pacientes mayores de 18 anos con los siguientes tipos de neoplasias mieloproliferativas: policitemia Vera, trombocitemia esencial, mielofibrosis idiopatica, leucemia eosinofilica cronica, neoplasia mieloproliferativa asociadas a eosinofilia (con rearreglo PDGFRA, PDGFRB y FGFR1) y neoplasias mieloproliferativas no clasificables.
Since PDGFRB and B-RAF work cooperatively, keeping both turned off causes synergistic effects in tumours, according to Cheresh.
In the 2008 World Health Organization classification system, the category of MPNs includes chronic myelogenous leukemia; chronic neutrophilic leukemia; polycythemia vera; primary myelofibrosis; essential thrombocythemia; chronic eosinophilic leukemia; mastocytosis; and MPN, unclassifiable; and the clinical and pathologic findings may overlap with the category of myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
In a phase II open-label trial--Study B2225, the largest study involving patients with DFSP)--imatinib mesylate, an inhibitor of PDGFRB, was found to be safe and effective in the treatment of patients with locally advanced and metastatic DFSP tumors containing t(17;22) translocation.
Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed to detect gene rearrangements of BCR / ABL , FIPIL1/PDGFRA , TEL / PDGFRB were all negative as well as c-KIT and JAK2V617F mutations.
Crenolanib is a selective inhibitor of PDGFRA and PDGFRB that has been reported to inhibit the PDGFRA D842V mutant kinase and to be 100- to 150-fold more potent than imatinib against that mutation.
These neoplasms respond to tyrosine kinase inhibitors and are addressed below in the section "Myeloid Neoplasms Associated With Eosinophilia and Abnormalities of PDGFRB.
Acronyms browser ?
Full browser ?
- PDGFA-Associated Protein 1
- PDGFRA/BCR fusion
- PDH complex
- PDH complex